You are here: Industry Insights > Revive Therapeutics

News List

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19 FirstWordPharma
December 30, 2021
Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders...
Revive Therapeutics partners with Complete Phytochemical Solutions to advance research initiatives for psilocybin-based pharmaceutical products pharmaceutical-business-review
April 22, 2020
Revive Therapeutics has engaged Complete Phytochemical Solutions, which specialises in unique and complex analyses and formulation development of phytochemicals.
Revive Therapeutics Applies To FDA For Orphan Drug Designation of Cannabidiol For Treatment Of Liver Transplantation pharmafocusasia
November 27, 2018
Revive Therapeutics Ltd., a specialty medical cannabis company, today announced that it has submitted an application to the U.S. Food and Drug Administration (“FDA”) seeking ...